ConductScience.org, home

Paper833262

Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.

Ortiz A and 4 others. J Clin Endocrinol Metab, 1977. Cited by 170 papers, by iCite.

Cite this record

ConductScience Library. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. Papers, record 833262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/833262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
170
iCite
Relative citation ratio, by iCite
6.63
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ortiz AA
2Hirol MM
3Stanczyk FZF Z
4Goebelsmann UU
5Mishell DRD R

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MedroxyprogesteroneMajor topic
OvaryMajor topic
Adult
Delayed-Action Preparations
Estradiol
Female
Humans
Injections, Intramuscular
Progesterone

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03395756Depot Medroxyprogesterone Acetate as Emergency ContraceptionBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 170 citations.

PMIDTitleJournalYearIn PapersSource
41489365Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†.Biol Reprod2026https://conductscience.org/library/papers/41489365PubMed
39106301U.S. Selected Practice Recommendations for Contraceptive Use, 2024.MMWR Recomm Rep2024https://conductscience.org/library/papers/39106301PubMed
36899465Genital epithelial barrier function is conserved by intravaginal rings releasing etonogestrel and ethinyl estradiol.Tissue Barriers2024https://conductscience.org/library/papers/36899465PubMed
36604469New approaches for developing biomarkers of hormonal contraceptive use.Sci Rep2023https://conductscience.org/library/papers/36604469PubMed
35964796Variability and quantification of serum medroxyprogesterone acetate levels.Steroids2022https://conductscience.org/library/papers/35964796PubMed
35370982Prenatal Progestin Exposure-Mediated Oxytocin Suppression Contributes to Social Deficits in Mouse Offspring.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35370982PubMed
35281554Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate.Contracept X2022https://conductscience.org/library/papers/35281554PubMed
35128365Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial.EClinicalMedicine2022https://conductscience.org/library/papers/35128365PubMed
34853394Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.Sci Rep2021https://conductscience.org/library/papers/34853394PubMed
34578224Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity.Pathogens2021https://conductscience.org/library/papers/34578224PubMed
34151439A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment.Clin Pharmacol Ther2021https://conductscience.org/library/papers/34151439PubMed
33619020Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.Cancer Epidemiol Biomarkers Prev2021https://conductscience.org/library/papers/33619020PubMed
33367229The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive.Contracept X2021https://conductscience.org/library/papers/33367229PubMed
33316287Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.Pharmacol Ther2021https://conductscience.org/library/papers/33316287PubMed
33300612Effects of medroxyprogesterone acetate on social behavior in female rhesus macaques (Macaca mulatta) depend on male breeding season introductions.J Med Primatol2021https://conductscience.org/library/papers/33300612PubMed
31504342
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Clin Infect Dis2020https://conductscience.org/library/papers/31504342PubMed
31374188Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi.Contraception2019https://conductscience.org/library/papers/31374188PubMed
31001262Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.Front Immunol2019https://conductscience.org/library/papers/31001262PubMed
30867477The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.Sci Rep2019https://conductscience.org/library/papers/30867477PubMed
30816632Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.J Int AIDS Soc2019https://conductscience.org/library/papers/30816632PubMed

See all 47 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/833262

GET https://conductscience.org/api/papers/v1/833262/cited_by?page=2